These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 5392487

  • 1. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
    Inagaki A, Nakamura T, Wakisaka G.
    Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487
    [No Abstract] [Full Text] [Related]

  • 2. Selective toxicity of rifamycin derivatives for leukaemic human leucocytes.
    Smith RG, Whang-Peng J, Gallo RC, Levine P, Ting RC.
    Nat New Biol; 1972 Apr 12; 236(67):1166-71. PubMed ID: 4503730
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA, DeConti RC, Kaplan SR.
    Cancer Res; 1968 Jun 12; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract] [Full Text] [Related]

  • 4. [Inhibition of DNA synthesis in peripheral leukemic cells by cytosine-arabinoside; attempt at deriving therapeutic application].
    Schleusner A, Schütt M, Langen P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Jun 12; 108(2):218-25. PubMed ID: 6168530
    [No Abstract] [Full Text] [Related]

  • 5. Anticancer effects of propanals: comparison between human and animal tumor systems.
    Apple MA, Cline MJ.
    Natl Cancer Inst Monogr; 1971 Dec 12; 34():161-5. PubMed ID: 5140861
    [No Abstract] [Full Text] [Related]

  • 6. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Graham FL, Whitmore GF.
    Cancer Res; 1970 Nov 12; 30(11):2636-44. PubMed ID: 5530558
    [No Abstract] [Full Text] [Related]

  • 7. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
    Wilmanns W.
    Natl Cancer Inst Monogr; 1971 Dec 12; 34():153-9. PubMed ID: 5291099
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
    Chou TC, Burchenal JH, Schmid FA, Braun TJ, Su TL, Watanabe KA, Fox JJ, Philips FS.
    Cancer Res; 1982 Oct 12; 42(10):3957-63. PubMed ID: 7104996
    [No Abstract] [Full Text] [Related]

  • 9. Pyrimidine metabolism in human leukocytes. I. Contribution of exogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukemic leukocytes.
    Cooper RA, Perry S, Breitman TR.
    Cancer Res; 1966 Nov 12; 26(11):2267-75. PubMed ID: 5225414
    [No Abstract] [Full Text] [Related]

  • 10. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH, Carter CJ, Brown NS, Hester J, McCredie K, Benjamin RS, Freireich EJ, Bodey GP.
    Cancer Res; 1980 Jul 12; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract] [Full Text] [Related]

  • 11. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H.
    Cancer Chemother Pharmacol; 2003 Dec 12; 52(6):497-506. PubMed ID: 12955470
    [Abstract] [Full Text] [Related]

  • 12. [DNA synthesis of leukemic leukocytes].
    Rainer H, Piller G, Moser K.
    Verh Dtsch Ges Inn Med; 1973 Dec 12; 79():383-7. PubMed ID: 4790238
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A micro-system for screening anti-leukemic drugs utilizing human whole blood.
    Farrow MG, Van Dyke K.
    Chemotherapy; 1971 Dec 12; 16(2):76-84. PubMed ID: 5120611
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE, Ford SS, Occhipinti SJ, Ritch PS, Riccardi R, Erickson BW.
    Cancer Res; 1982 Nov 12; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract] [Full Text] [Related]

  • 18. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A, Kanzawa F, Kuretani K, Kanai T, Ichino M.
    Biochem Pharmacol; 1973 Nov 15; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.